KMB vs LLY · P/E 19, rev $8.35B vs P/E 39, rev $22.97B
Kimberly-Clark Corporation (KMB) versus Eli Lilly and Company (LLY) — a side-by-side from cached financials, not a winner call.
Kimberly-Clark Corporation (KMB) is a household & personal products company listed on US.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Latest reported KMB revenue for 2026-06-30 was $8.35B. Net income was $1.01B. KMB currently screens at market cap $32.88B and trailing P/E 19.2.
Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
KMB currently screens at market cap $32.88B and trailing P/E 19.2. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Not investment advice. Open the KMB and LLY stock pages for the full models.
Not investment advice.